Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The role of the NOD2/CARD15 gene in surgical treatment prediction in patients with Crohn's disease

L. Kunovsky, Z. Kala, F. Marek, J. Dolina, K. Poredska, L. Kucerova, K. Benesova, L. Mitas,

. 2019 ; 34 (2) : 347-351. [pub] 20180802

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19028290

PURPOSE: Crohn's disease (CD) belongs to chronic disorders with unpredictable disease course. The aim of this study was to identify how genetic testing (NOD2/CARD15) can be used in patients with CD to predict the need for surgical treatment (to define an aggressive type of disease where the patient can profit from early surgery). METHODS: The patients who were tested genetically had undergone a surgery due to CD at the Department of Surgery University Hospital Brno Bohunice between 2010 and 2016. The control group consisted of patients with CD who had been diagnosed with CD at least 5 years prior to the testing and had not required any surgical intervention. The second control group was healthy subjects. RESULTS: In total, there were 117 operated patients for CD, 77 patients with CD that had not undergone surgery for CD and 30 healthy subjects. For patients with at least one genetic mutation, the risk of the necessity of surgical treatment of CD is 1.96 times higher than for patients with no mutation. Patients with two or more mutations were generally operated on at a younger age, in a shorter time after being diagnosed and each patient had a partial resection of the ileum. CONCLUSION: The group of operated patients with CD had a significantly higher distribution of at least one genetic mutation as opposed to the non-operated group. In patients with two or more mutations, the disease course was more aggressive. This group of patients might profit from the conservative top-down or early surgical therapy.

000      
00000naa a2200000 a 4500
001      
bmc19028290
003      
CZ-PrNML
005      
20190823085012.0
007      
ta
008      
190813s2019 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00384-018-3122-7 $2 doi
035    __
$a (PubMed)30069743
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Kunovsky, L $u Department of Surgery, University Hospital Brno Bohunice, Faculty of Medicine, Masaryk University, Jihlavska 20, 62500, Brno, Czech Republic. Department of Gastroenterology, University Hospital Brno Bohunice, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
245    14
$a The role of the NOD2/CARD15 gene in surgical treatment prediction in patients with Crohn's disease / $c L. Kunovsky, Z. Kala, F. Marek, J. Dolina, K. Poredska, L. Kucerova, K. Benesova, L. Mitas,
520    9_
$a PURPOSE: Crohn's disease (CD) belongs to chronic disorders with unpredictable disease course. The aim of this study was to identify how genetic testing (NOD2/CARD15) can be used in patients with CD to predict the need for surgical treatment (to define an aggressive type of disease where the patient can profit from early surgery). METHODS: The patients who were tested genetically had undergone a surgery due to CD at the Department of Surgery University Hospital Brno Bohunice between 2010 and 2016. The control group consisted of patients with CD who had been diagnosed with CD at least 5 years prior to the testing and had not required any surgical intervention. The second control group was healthy subjects. RESULTS: In total, there were 117 operated patients for CD, 77 patients with CD that had not undergone surgery for CD and 30 healthy subjects. For patients with at least one genetic mutation, the risk of the necessity of surgical treatment of CD is 1.96 times higher than for patients with no mutation. Patients with two or more mutations were generally operated on at a younger age, in a shorter time after being diagnosed and each patient had a partial resection of the ileum. CONCLUSION: The group of operated patients with CD had a significantly higher distribution of at least one genetic mutation as opposed to the non-operated group. In patients with two or more mutations, the disease course was more aggressive. This group of patients might profit from the conservative top-down or early surgical therapy.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a alely $7 D000483
650    _2
$a Crohnova nemoc $x genetika $x chirurgie $7 D003424
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a genetické asociační studie $7 D056726
650    _2
$a genetická predispozice k nemoci $7 D020022
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mutace $x genetika $7 D009154
650    _2
$a signální adaptorový protein Nod2 $x genetika $7 D053473
650    _2
$a prognóza $7 D011379
650    _2
$a rizikové faktory $7 D012307
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kala, Z $u Department of Surgery, University Hospital Brno Bohunice, Faculty of Medicine, Masaryk University, Jihlavska 20, 62500, Brno, Czech Republic.
700    1_
$a Marek, F $u Department of Surgery, University Hospital Brno Bohunice, Faculty of Medicine, Masaryk University, Jihlavska 20, 62500, Brno, Czech Republic. fillip.marek@email.cz.
700    1_
$a Dolina, J $u Department of Gastroenterology, University Hospital Brno Bohunice, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
700    1_
$a Poredska, K $u Department of Gastroenterology, University Hospital Brno Bohunice, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
700    1_
$a Kucerova, L $u Department of Gastroenterology, University Hospital Brno Bohunice, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
700    1_
$a Benesova, K $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic. Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic.
700    1_
$a Mitas, L $u Department of Surgery, University Hospital Brno Bohunice, Faculty of Medicine, Masaryk University, Jihlavska 20, 62500, Brno, Czech Republic.
773    0_
$w MED00002307 $t International journal of colorectal disease $x 1432-1262 $g Roč. 34, č. 2 (2019), s. 347-351
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30069743 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20190823085227 $b ABA008
999    __
$a ok $b bmc $g 1433439 $s 1066750
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 34 $c 2 $d 347-351 $e 20180802 $i 1432-1262 $m International journal of colorectal disease $n Int J Colorectal Dis $x MED00002307
LZP    __
$a Pubmed-20190813

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...